915 related articles for article (PubMed ID: 33955623)
1. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.
Gülsen A; König IR; Jappe U; Drömann D
Respirology; 2021 Jun; 26(6):552-565. PubMed ID: 33955623
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
3. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
Oh TK; Song IA
BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
[TBL] [Abstract][Full Text] [Related]
5. Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases.
Guan WJ; Liang WH; Shi Y; Gan LX; Wang HB; He JX; Zhong NS
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2645-2655.e14. PubMed ID: 33684635
[TBL] [Abstract][Full Text] [Related]
6. Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.
Gemicioglu B; Uzun H; Borekci S; Karaali R; Kurugoglu S; Atukeren P; Sirolu S; Durmus S; Dirican A; Kuskucu MA; Tabak F
J Infect Dev Ctries; 2021 Oct; 15(10):1415-1425. PubMed ID: 34780364
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
8. Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease.
Whittaker H; Kallis C; Bolton T; Wood A; Walker S; Sheikh A; Brownrigg A; Akbari A; Sterniczuk K; Quint JK;
Int J Epidemiol; 2024 Apr; 53(3):. PubMed ID: 38850276
[TBL] [Abstract][Full Text] [Related]
9. Asthma and COVID-19 in children: A systematic review and call for data.
Castro-Rodriguez JA; Forno E
Pediatr Pulmonol; 2020 Sep; 55(9):2412-2418. PubMed ID: 32558360
[TBL] [Abstract][Full Text] [Related]
10. Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.
Dixit S; Borghi-Silva A; Bairapareddy KC
Rev Cardiovasc Med; 2021 Jun; 22(2):315-327. PubMed ID: 34258900
[TBL] [Abstract][Full Text] [Related]
11. Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population.
Huang BZ; Chen Z; Sidell MA; Eckel SP; Martinez MP; Lurmann F; Thomas DC; Gilliland FD; Xiang AH
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3621-3628.e2. PubMed ID: 34389242
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
13. Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.
Aggarwal AN; Prasad KT; Muthu V
Curr Opin Pulm Med; 2022 Mar; 28(2):84-92. PubMed ID: 34652297
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
15. Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis.
Uruma Y; Manabe T; Fujikura Y; Iikura M; Hojo M; Kudo K
PLoS One; 2022; 17(11):e0276774. PubMed ID: 36318528
[TBL] [Abstract][Full Text] [Related]
16. Progression to a severe form of COVID-19 among patients with chronic respiratory diseases.
Basin S; Valentin S; Maurac A; Poussel M; Pequignot B; Brindel A; Poupet G; Robert C; Baumann C; Luc A; Soler J; Chabot F; Chaouat A
Respir Med Res; 2022 May; 81():100880. PubMed ID: 34974204
[TBL] [Abstract][Full Text] [Related]
17. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease.
Andreen N; Andersson LM; Sundell N; Gustavsson L; Westin J
Infect Dis (Lond); 2022 Jul; 54(7):508-513. PubMed ID: 35287524
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
19. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
Timberlake DT; Strothman K; Grayson MH
Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
He Y; Xie M; Zhao J; Liu X
Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
